§ Funding Round
Series A funding round for Transition Bio raising $50M in June 2022
Series A funding round for Transition Bio raising $50M in June 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
Bristol Myers Squibb | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$50M
Top Valuation
-
Transition Bio, Inc. raised $50M in a Series A round.
The round was announced on 06/01/22.
The round was led by Northpond Ventures.
